Isaac Klapper was 10 years old when he started having episodes of what doctors initially thought was a movement disorder.

J.P. Morgan’s U.S. equity analysts picked their top stocks for 2025 in healthcare, selecting “the most compelling investment ...

An ongoing campaign to fund medical cannabis for the East Kilbride boy, who has rare drug resistant focal epilepsy, has stepped up a gear following the return of his crippling seizures.

Over the past 4-5 years, the PGIMER has successfully integrated awake craniotomy into its routine practice for adult patients ...

Biohaven Ltd.’s BHV-7000, a selective Kv7.2/7.3 potassium channel activator, is in phase II/III development for the treatment ...

The company’s pipeline products include XEN1101, NBI-921352, and XEN496. XEN1101 is a differentiated Kv7 potassium channel opener under development to treat focal onset seizures, major depressive ...

Noida police apprehended 156 rewarded criminals since January of last year, including one with a ₹1 lakh bounty. Over 100 ...

Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications, new ...

This article summarises a LivaNova-sponsored symposium entitled ‘The Power of Real-World Evidence with CORE-VNS’, delivered ...

Of all the flashpoints facing the Trump administration on Jan. 20, 2025, China’s campaign of intimidation and maritime ...

LOS ANGELES -- Low racial diversity has limited genome-wide association studies (GWAS) in epilepsy, researchers found, with ...

Epidiolex is showing positive results for treating TSC, adding to its success with addressing Dravat Syndrome and Lennox ...